Does everyone develop covert cancer?

Journal name:
Nature Reviews Cancer
Volume:
14,
Pages:
209–210
Year published:
DOI:
doi:10.1038/nrc3703
Published online

Abstract

Around one in three individuals, if they live long enough, will have a confirmed clinical diagnosis of overt cancer, and there is increasing evidence that many of us — I contend all of us — develop covert cancer.

References

  1. Sakr, W. A. et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J. Urol. 150, 379385 (1993).
  2. Welch, H. G. & Black, W. C. Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann. Int. Med. 127, 10231028 (1997).
  3. Mori, H. et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl Acad. Sci. USA 99, 82428247 (2002).
  4. Ståhl, P. L. et al. Sun-induced nonsynonymous p53 mutations are extensively accumulated and tolerated in normal appearing human skin. J. Invest. Dermatol. 131, 504508 (2011).
  5. Welch, J. S. et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264278 (2012).
  6. Greaves, M. Darwinian medicine: a case for cancer. Nature Rev. Cancer 7, 213221 (2007).
  7. Bissell, M. J. & Hines, W. C. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nature Med. 17, 320329 (2011).
  8. Esserman, L. J., Thompson, I. M. Jr & Reid, B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. J. Am. Med. Assoc. 310, 797798 (2013).
  9. Maley, C. C. et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genet. 38, 468473 (2006).
  10. Kostadinov, R. L. et al. NSAIDs modulate clonal evolution in Barrett's esophagus. PLoS Genet. 9, e1003553 (2013).

Download references

Author information

Affiliations

  1. Centre for Evolution and Cancer, The Institute of Cancer Research, Brookes Lawley Building, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.

    • Mel Greaves

Competing interests statement

The author declares no competing interests.

Corresponding author

Correspondence to:

Author details

Additional data